This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: AMZN, FTR, GRPN

Stocks in this article: AMZN FTR GRPN ATK ANF

Texas Instruments (TXN) was downgraded at UBS to Neutral from Buy. $35 price target. Limited margin upside in near to mid term, UBS said.

Worthington (WOR) was upgraded at Goldman Sachs from Sell to Neutral. $18 price target. New engineered cabs business should boost earnings, Goldman said.

STOCK COMMENTS / EPS CHANGES

Charles River (CRL) numbers were increased at Sterne Agee. Estimates were raised through 2013. Checks show that customer demand is becoming stronger, Sterne Agee said.

CSX (CSX) was added to US1 list at Bank of America/Merrill Lynch. Valuation call, based on a new $26 price target, BofA/Merrill said.

CSX numbers were lowered at Jefferies. Shares are now seen reaching $28. Estimates were also lowered on mild weather, Jefferies said. Buy rating.

Discover Financial (DFS) numbers were boosted at Bank of America/Merrill Lynch. Estimates were also increased, as the company continues to operate in a sweet spot of the credit cycle. Buy rating.

Dover Corp. (DOV) numbers were raised at Credit Suisse. Shares are now seen reaching $69. Estimates were also raised on healthy book-to-bill and positive meetings with management, Credit Suisse said. Neutral rating.

Finish Line (FINL) numbers were reduced at Sterne Agee. Shares are now seen reaching $25. Estimates were also cut. Company is investing more on digital technologies, Sterne Agee said. Buy rating.

Groupon (GRPN - Get Report) estimates, target cut at Benchmark. Shares are now seen reaching $28. Estimates were also reduced, given higher refund amounts, Benchmark said. Overweight rating.

Pfizer (PFE) price target was increased at Citigroup to $23. Divestitures are on track, but there is no plan to break up the pharma business, Citigroup said.

Pier One (PIR) numbers were raised at Keybanc. Shares are now seen reaching $21. Estimates were also increased, as a cyclical spending recovery should continue to unfold over the coming quarters, Keybanc said.

Qualcomm (QCOM) estimates and target were raised at Bank of America/Merrill Lynch. Shares are now seen reaching $75. Estimates also increased, as the company is leveraged to higher global handset growth, BofA/Merrill said. Buy rating.

Starbucks (SBUX) price target was raised to $70 at Williams Capital. Company is expanding with new products and locations, Williams said. Outperform rating.

Schlumberger (SLB) estimates and target were lowered at Dahlman Rose. Estimates were cut through 2013. Company is seeing lower North American pressure pumping results, Dahlman Rose said. Buy rating and new $89 price target.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs